Results 111 to 120 of about 23,536 (214)

Network pharmacology, molecular docking and <i>In vivo</i> validation reveal the neuroprotective effects of TT-TeMac™ against cholinergic dysfunction and hippocampal lesions. [PDF]

IBRO Neurosci Rep
Ambamba BDA, Jonathan MMN, Marc AFY, Sandrine NM, Reine NMI, Emmanuel N, Laurent NA, Blonde NEM, Alexandra EEF, Ella FA, Mandob DE, Ngondi JL.   +11 more
europepmc   +1 more source

Blood Metabolomic Profiling of Systemic Responses to Dried Black Lychee in a Scopolamine-Induced Cognitive Impairment in Rats. [PDF]

Biology (Basel)
Weerateerangkul P, Kangwan N, Jeefoo WP, Kobroob A, Konguthaithip G, Intui K, Watcharakhom S, Kulprachakarn K, Chaipoot S, Parklak W, Chuljerm H, Samoechai S, Piengjaikum N, Namdech S, Laoung-On J, Jaikang C.   +15 more
europepmc   +1 more source

Evaluation of the Neuroprotective Effects of Diospyros discolor and Diospyros ebenum Leaf Bioactive Fractions In Vivo and Their UPLC-ESI-MS/MS Chemical Characterization: A Comparative Study. [PDF]

J Food Sci
Fareed N, Youssef FS, Labib RM, Tawfiq R, El-Kersh DM.   +4 more
europepmc   +1 more source

"Behavioral and Neuroinflammatory Evaluation of a Novel Isoxazole-5-One Derivative in Animal Models of Alzheimer's Disease via TNF-α, COX-2, IL-6, and NF-κB Modulation". [PDF]

ACS Omega
Gohar N, Abbas M, Masaud SM, Zulfiqar I, Jabeen H, Malik NS, Nadeem H.   +6 more
europepmc   +1 more source

Scopolamine Prevents Dreams during General Anesthesia

, 2007
BACKGROUND: Dreaming during anesthesia is not a well-understood phenomenon. Anticholinergic drugs are used in anesthesia as premedication, but their use to decrease the incidence of dreams and psychological adverse reactions after anesthesia is not well ...
PEDUTO, Vito, Adelchi T., Pancaro C.
core  

Behavioral and Biochemical Evaluation of a Curcumin-Loaded Nano-Liposomal Formulation in a Scopolamine-Induced Mouse Model of Cognitive Impairment. [PDF]

Biomol Ther (Seoul)
Lee HY, Hossain MK, Jang GH, Lee H, Kim YM, Chae HJ.   +5 more
europepmc   +1 more source

Scopolamine?

Journal of the American College of Cardiology, 2002
openaire   +2 more sources

Scopolamine (hyoscine) for preventing and treating motion sickness

, 2009
Background: This is an update of a Cochrane Review first published in The Cochrane Library in Issue 3, 2004 and previously updated in 2007. Motion sickness, the discomfort experienced when perceived motion disturbs the organs of balance, may include ...
Spinks, Anneliese, Wasiak, Jason, Bernath, Vivienne, Villanueva, Elmer   +3 more
core  

Fabrication and efficacy evaluation of scopolamine-loaded dissolving microneedle for rapid antidepressant therapy. [PDF]

Int J Pharm X
Wang Y, Shi Y, Chen Q, Hu M, Zhao Y, Ren W, Liu K, Hou F, Cui Y, Ma Y, Xing M, Geng X.   +11 more
europepmc   +1 more source

Development and application of a radioreceptor assay for scopolamine

, 1988
6 beta,7 beta-Epoxy-3a(1aH,5aH)-tropanyl-(S)-tropate (scopolamine) has proved to be a very effective drug in the prevention of motion sickness, however, the drug has a small therapeutic window, a low bioavailability and a short half-life.
Ensing, K., Klinkers, H. M. J., in 't Hout, W. G., Halma, P., de Zeeuw, R. A., Ensing, G. J.   +5 more
core